Representatives of AUMED participated in the XL. Congress of Slovak and Czech allergists and clinical immunologists, which took place in Horní Smokovec. AUMED had its own promotional stand at the congress, focused mainly on the immunological preparation TFI. In the form of posters, leaflets and personal interviews, we shared our successes from product development and preclinical studies with the professional public.
The transfer factor-based TFI was a huge success, and many immunologists regretted that the product was not yet registered and could not be prescribed to patients. The entire congress was also very thematically oriented to the issue of transfer factors, including a focus on historical use in our territory.
We believe that AUMED will successfully conduct clinical trials of TFI and soon we will be able to inform medical professionals about the availability of the product on the market.
Our subsidiary Aumed Pharma a.s. launches food supplement Gut Guard. Gut Guard probiotics contain a combination of 13 vital probiotic…
AUMED received support for the project “Development of an antibacterial preparation with phages for recurrent bacterial vaginosis”, registration number CZ.01.01.01/01/22_002/0000523….
AUMED received support for the project “Development of a new vaccine against Staphylococcus aureus”, registration number CZ.01.01.01/01/22_002/0000585. Staphylococcus aureus causes…
Research projects of Aumed, a.s. are financed by the European Structural Funds and with financial support from the state budget through the Ministry of Industry and Trade. A complete list of all ongoing and completed projects with this support can be found here.
Ministry of Industry and Trade
Program TRIO
European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness
Tel.: +420 603 587 701
Komořanská 326/63, 143 14 Praha - Modřany, Česká republika
(c) 2017, Aumed a.s
